Shopping Cart
- Remove All
![TargetMol](https://newstatic.targetmol.com/error/oops.webp)
Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $58 | In Stock | |
10 mg | $92 | In Stock | |
25 mg | $171 | In Stock | |
50 mg | $277 | In Stock | |
100 mg | $443 | In Stock | |
200 mg | $621 | In Stock | |
500 mg | $925 | In Stock | |
1 mL x 10 mM (in DMSO) | $58 | In Stock |
Description | Tucidinostat (Chidamide) is an effective and orally bioavailable HDAC enzymes class I (HDAC1/2/3) and class IIb (HDAC10) inhibitor, with IC50s of 95, 160, 67 and 78 nM, less active on HDAC8/11 (IC50: 733/432 nM), and shows no effect on HDAC4/5/6/7/9. |
In vitro | Tucidinostat shows potent antitumor activity and inhibits several human-derived tumour cell lines, such as HL-60, U2OS, LNCaP with GI50s of 0.4 ± 0.1, 2.0 ± 0.6, and 4.0 ± 1.2 μM, respectively. In addition, Tucidinostat shows less toxic to normal cells from human fetal kidney (CCC-HEK) and liver (CCCHEL)[1]. |
In vivo | Tucidinostat, administered orally at doses ranging from 12.5 to 50 mg/kg, effectively and dose-dependently decreases tumor size and weight in mice afflicted with various carcinomas including HCT-8 colorectal, A549 lung, BEL-7402 liver, and MCF-7 breast, without any significant loss in body weight[1]. |
Alias | HBI-8000, Chidamide, CS 055 |
Molecular Weight | 390.41 |
Formula | C22H19FN4O2 |
Cas No. | 1616493-44-7 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | ||||||||||||||||||||||||||||||||||||||||
Solubility Information | 5% DMSO+95% Saline: 2.5 mg/mL (6.4 mM, precipitation) ![]() DMSO: 60 mg/mL (153.68 mM) ![]() Ethanol: 1 mg/mL H2O: Insoluble | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
DMSO/5% DMSO+95% Saline
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.